Similar articles for PMID: 22834780

Year	Number of Results
1996	1
1998	2
2001	1
2002	1
2003	2
2004	4
2005	2
2006	3
2007	5
2008	6
2009	5
2010	8
2011	12
2012	5
2013	8
2014	2
2015	7
2016	4
2017	1
2018	4
2019	6
2020	6
2021	6
2022	2
2024	0

1

Ron receptor tyrosine kinase signaling as a therapeutic target.

Benight NM, Waltz SE. Benight NM, et al. Expert Opin Ther Targets. 2012 Sep;16(9):921-31. doi: 10.1517/14728222.2012.710200. Epub 2012 Jul 26. Expert Opin Ther Targets. 2012. PMID: 22834780 Free PMC article. Review.

2

Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.

Bieniasz M, Radhakrishnan P, Faham N, De La O JP, Welm AL. Bieniasz M, et al. Clin Cancer Res. 2015 Dec 15;21(24):5588-600. doi: 10.1158/1078-0432.CCR-14-3283. Epub 2015 Aug 19. Clin Cancer Res. 2015. PMID: 26289070 Free PMC article.

3

RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.

Faham N, Welm AL. Faham N, et al. Cold Spring Harb Symp Quant Biol. 2016;81:177-188. doi: 10.1101/sqb.2016.81.031377. Epub 2017 Jan 5. Cold Spring Harb Symp Quant Biol. 2016. PMID: 28057847 Review.

4

Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.

Lu Y, Yao HP, Wang MH. Lu Y, et al. Cancer Lett. 2007 Nov 18;257(2):157-64. doi: 10.1016/j.canlet.2007.08.007. Epub 2007 Sep 21. Cancer Lett. 2007. PMID: 17889431 Review.

5

The ron receptor tyrosine kinase: a key regulator of inflammation and cancer progression.

Wang X, Hankey PA. Wang X, et al. Crit Rev Immunol. 2013;33(6):549-74. doi: 10.1615/critrevimmunol.2013007953. Crit Rev Immunol. 2013. PMID: 24266348 Review.

6

Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

McClaine RJ, Marshall AM, Wagh PK, Waltz SE. McClaine RJ, et al. Neoplasia. 2010 Aug;12(8):650-8. doi: 10.1593/neo.10476. Neoplasia. 2010. PMID: 20689759 Free PMC article.

7

Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Wagh PK, Peace BE, Waltz SE. Wagh PK, et al. Adv Cancer Res. 2008;100:1-33. doi: 10.1016/S0065-230X(08)00001-8. Adv Cancer Res. 2008. PMID: 18620091 Free PMC article. Review.

8

Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.

Kim SA, Lee KH, Lee DH, Lee JK, Lim SC, Joo YE, Chung IJ, Noh MG, Yoon TM. Kim SA, et al. Int J Oncol. 2019 Aug;55(2):513-526. doi: 10.3892/ijo.2019.4836. Epub 2019 Jul 2. Int J Oncol. 2019. PMID: 31268163

9

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Catenacci DV, Cervantes G, Yala S, Nelson EA, El-Hashani E, Kanteti R, El Dinali M, Hasina R, Brägelmann J, Seiwert T, Sanicola M, Henderson L, Grushko TA, Olopade O, Karrison T, Bang YJ, Kim WH, Tretiakova M, Vokes E, Frank DA, Kindler HL, Huet H, Salgia R. Catenacci DV, et al. Cancer Biol Ther. 2011 Jul 1;12(1):9-46. doi: 10.4161/cbt.12.1.15747. Epub 2011 Jul 1. Cancer Biol Ther. 2011. PMID: 21543897 Free PMC article.

10

Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.

Thangasamy A, Rogge J, Ammanamanchi S. Thangasamy A, et al. J Biol Chem. 2009 May 22;284(21):14001-10. doi: 10.1074/jbc.M809320200. Epub 2009 Mar 23. J Biol Chem. 2009. PMID: 19307182 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year